IGM Biosciences, Inc.
MULTIMERIC SARS-COV-2 BINDING MOLECULES AND USES THEREOF
Last updated:
Abstract:
This disclosure provides multimeric binding molecules that bind to SARS-CoV-2. This disclosure also provides compositions comprising the multimeric binding molecules, polynucleotides that encode the multimeric binding molecules, and host cells that can produce the binding molecules. Further this disclosure provides methods of using the multimeric binding molecules, including methods for treating and preventing coronavirus disease 2019 (COVID-19).
Status:
Application
Type:
Utility
Filling date:
15 Feb 2022
Issue date:
25 Aug 2022